ScreenerHero
CDNACareDx, Inc.
NAS · US · Healthcare · Diagnostics & Research · caredx.com
40.34USD+35.60%Mkt Cap: 2.08B $P/E: —

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$201.86BUSDP/E 29.8
DHR
Danaher Corporation
$145.10BUSDP/E 39.7
LONN
Lonza Group AG
$45.85BUSDP/E 44.2
IDXX
IDEXX Laboratories, Inc.
$45.44BUSDP/E 42.4
NTRA
Natera, Inc.
$38.64BUSD
A
Agilent Technologies, Inc.
$38.44BUSDP/E 27.3
WAT
Waters Corporation
$37.13BUSDP/E 48.1
IQV
IQVIA Holdings Inc.
$35.13BUSDP/E 26.2
ILMN
Illumina, Inc.
$28.78BUSDP/E 34.6
MTD
Mettler-Toledo International Inc.
$26.98BUSDP/E 31.4
DGX
Quest Diagnostics Incorporated
$23.18BUSDP/E 23.1
LH
Labcorp Holdings Inc.
$23.12BUSDP/E 25.0
GH
Guardant Health, Inc.
$20.55BUSD
MEDP
Medpace Holdings, Inc.
$15.36BUSDP/E 33.9
ERF
Eurofins Scientific SE
$13.06BUSDP/E 27.3
RVTY
Revvity, Inc.
$12.46BUSDP/E 53.7
CRL
Charles River Laboratories International, Inc.
$11.04BUSD
BIM
bioMérieux S.A.
$9.26BUSDP/E 21.6
BLLN
BillionToOne, Inc.
$5.90BUSDP/E 237.4
TWST
Twist Bioscience Corporation
$5.68BUSD
SHC
Sotera Health Company
$5.21BUSDP/E 44.6
RDNT
RadNet, Inc.
$4.95BUSD
VCYT
Veracyte, Inc.
$4.73BUSDP/E 54.8
DIA
DiaSorin S.p.A.
$3.75BUSDP/E 26.5
ADPT
Adaptive Biotechnologies Corporation
$3.54BUSD
GRAL
GRAIL, Inc.
$3.09BUSD
NEO
NeoGenomics, Inc.
$1.93BUSD
WGS
GeneDx Holdings Corp.
$1.83BUSD
VIMIAN
Vimian Group AB (publ)
$1.64BUSDP/E 41.7
PSNL
Personalis, Inc.
$1.63BUSD
DIA
Diagnostyka S.A.
$1.48BUSDP/E 22.4
CBAV
Clínica Baviera, S.A.
$1.02BUSDP/E 21.4
OPK
OPKO Health, Inc.
$898.56MUSD
CSTL
Castle Biosciences, Inc.
$734.89MUSD
LBIRD
Lumibird SA
$616.40MUSDP/E 40.2
MYGN
Myriad Genetics, Inc.
$584.63MUSD
FLGT
Fulgent Genetics, Inc.
$583.63MUSD
VOX
Voxel S.A.
$293.12MUSDP/E 2.9
EDT
Spectral Medical Inc.
$292.75MUSD
BDSX
Biodesix, Inc.
$206.70MUSD
IMDX
Insight Molecular Diagnostics Inc.
$152.09MUSD
SLV
Selvita S.A.
$139.43MUSD
SCP
Scope Fluidics S.A.
$97.25MUSD
XGN
Exagen Inc.
$102.68MUSD
ALECR
Eurofins-Cerep SA
$89.37MUSDP/E 17.2
BIOPOR
BioPorto A/S
$73.19MUSD
PANG
Pangaea Oncology, S.A.
$58.55MUSD
PRPO
Precipio, Inc.
$42.32MUSD
NN6
NanoRepro AG
$30.71MUSD
ABDX
Abingdon Health Plc
$26.61MUSD
GDR
genedrive plc
$20.94MUSD
SENZA
SenzaGen AB
$16.60MUSD
IMMNOV
Immunovia AB (publ)
$12.04MUSD
BMX
BioMaxima S.A.
$9.95MUSD
VRCI
Verici Dx plc
$8.70MUSD
XWEL
XWELL, Inc.
$8.87MUSD
ALPRE
Predilife S.A.
$7.73MUSD
PRM
Proteome Sciences plc
$7.43MUSD
NDRA
ENDRA Life Sciences Inc.
$6.69MUSD
OBD
Oxford BioDynamics Plc
$6.06MUSD
AVCR
Avricore Health Inc.
$5.06MUSD
BIAF
bioAffinity Technologies, Inc.
$4.47MUSD
JUMP
Leveljump Healthcare Corp.
$4.44MUSD
PROGEN
Prostatype Genomics AB (publ)
$2.95MUSD
TELO
Telo Genomics Corp.
$3.29MUSD
ISPC
iSpecimen Inc.
$3.18MUSD
PRPH
ProPhase Labs, Inc.
$869.0KUSD
MBI-H
Many Bright Ideas Technologies Inc.
$314.2KUSDP/E Infinity
TTOO
T2 Biosystems, Inc.
$19.6KUSD
Indicators:|

Key Statistics

Company
Market Cap2.08B $
Enterprise Value1.92B $
Revenue (TTM)412.82M $
Gross Profit256.57M $
Net Income (TTM)-21.35M $
Revenue/Share7.899 USD
Last Price40.34 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees761
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS14167L1035
Valuation
P/E (Trailing)—
P/E (Forward)35.57
PEG—
EV/EBITDA829.56
EV/Revenue4.65
P/S5.05
P/B6.60
EPS (TTM)-0.16
EPS (Forward)1.13
52W Range
10.96100% of range40.38
52W High40.38 USD
52W Low10.96 USD
Profitability
Gross Margin67.55%
Oper. Margin1.53%
EBITDA Margin0.56%
Profit Margin-5.62%
ROE-7.05%
ROA-5.17%
Growth
Revenue Growth39.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF42.03M $
CapEx (TTM)6.59M $
FCF Margin16.99%
FCF Yield3.37%
Net Debt-162.68M $
Net Debt/EBITDA-70.24
Balance Sheet
Debt/Equity0.09
Current Ratio3.40
Quick Ratio2.93
Book Value/Sh6.115 USD
Cash/Share3.623 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)27.80 USD
Upside (mean)-31.1%
Target Range21.00 USD – 38.00 USD
$21.00-31.1% to mean$38.00
# Analysts5
Ownership
Shares Out.51.66M
Float49.25M
Insiders3.42%
Institutions101.72%
Short Interest
Short Ratio8.6d
Short % Float16.44%
Short % Out.16.14%
Shares Short8.34M
Short (prev mo.)6.37M
Technical
SMA 5024.18 (+66.8%)
SMA 20019.55 (+106.4%)
Beta2.43
S&P 52W Chg20.25%
Avg Vol (30d)937.08K
Avg Vol (10d)806.25K
Technical Indicators
RSI (14)86.2
MACD2.4415
MACD Signal1.8202
MACD Hist.+0.6212
BB Upper35.21 USD
BB Middle28.29 USD
BB Lower21.37 USD
BB Width48.91%
ATR (14)1.908 USD
Vol Ratio (20d)5.18x